On Nov. 26, Baxter confirmed with customers new allocation levels for several IV product groups. The announcement on the confirmation says that customers should expect a 1- to 2-week lag time for product to “flow through the full distribution network after allocation changes are implemented.”
The announcement added, “Barring any unanticipated developments, Baxter expects to share details on planned, phased increases in allocations again in mid-December and at year-end, which includes reaching 100% allocation across several IV product codes by the end of 2024.”
Further, the announcement said that Baxter’s ability to adjust allocation levels is based on the following:
- The current and projected status of its North Cove remediation efforts
- Its expectations regarding our ability to reallocate capacity from other Baxter facilities
- Temporary importation of certain products.
We last reported on Baxter on Nov. 25.
Janette Wider | Editor-in-Chief
Janette Wider is Editor-in-Chief for Healthcare Purchasing News.
